Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke

Overview of attention for article published in Frontiers in Pharmacology, April 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 12 X posts from 8 X users, with an upper bound of 172,203 followers.

Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke https://t.co/lvb43keOjy https://t.co/ddracaqK6v

RT @NatMed_Research: Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke http…

RT @PharmacyOnline8: Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke http…

RT @AdventAustralia: Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke http…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.